This systematic review and network meta-analysis found that spinal cord stimulation therapies for treatment of chronic pain in back and/or lower extremities were associated with greater improvements ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

Three times a week for eight weeks, half of the patients got 20 minutes of the spinal cord stimulation therapy, while the ...

A pilot clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found electrical stimulation of the spinal cord is feasible ... of HOPE for three 20-minute ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury ...

Philadelphia-based Rothman Orthopaedic Institute has been at the forefront of spine care, and recently a team partnered with Thomas Jefferson University Hospita ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Treatment may involve surgery, radiation therapy, chemotherapy, or other specialized target therapies. There are three main types of spinal cord tumors: intramedullary, intra-dural extramedullary, and ...

New research shows that stimulation of the lumbosacral vertebrae region significantly elevated low blood pressure, unlike cervical or upper thoracic stimulation.